Advertisement
Home Blog Page 2322
Children with autism spectrum disorder have increased odds of overweight/obesity compared with general population controls after adjustment for child co-occurring conditions

Odds of Overweight/Obesity Up for Children With Autism

0
Among children with ASD, those with severe symptoms more likely to be overweight/obese
A new clinical guideline for early-stage prostate cancer supports the use of shortened courses of radiation therapy

Hypofractionated Radiation OK for Localized Prostate CA

0
New multidisciplinary guideline for early-stage prostate cancer developed by three professional societies
Durvalumab results in significantly longer overall survival than placebo among patients with stage III

Durvalumab Extends Survival in Stage III Non-Small Cell Lung CA

0
Both overall and progression-free survival longer with durvalumab than with placebo
In an effort to cut high drug costs

Trump Administration Announces Plan to Cut Drug Prices

0
HHS study shows Medicare pays 80 percent more than other countries for certain prescription drugs
For men with low- and intermediate-risk prostate cancer

ASTRO: Long-Term Benefit for Stereotactic Radn in Prostate CA

0
Trials show high survival rates, freedom from recurrence for low-, intermediate-risk prostate cancer
Prior-season vaccination is not associated with reduced vaccine effectiveness among children aged 2 to 17 years

Prior-Season Vaccination Does Not Curb Flu Shot Effectiveness

0
Vaccine effectiveness in children varies by flu type, vaccine type but is not reduced with prior shots
Overall

Cancer Survival Higher in Teens, Young Adults Than Other Groups

0
Long-term data show teens, young adults had temporary dip in cancer survival due to HIV/AIDS
Cardiac implant prices are two to six times higher in the United States than in Germany

Cardiac Implant Prices Higher in U.S. Than EU Countries

0
However, there is significant price variation both within and between EU nations
For patients with locoregionally advanced human papillomavirus-related oropharynx cancer

ASTRO: Oropharynx CA Survival Rates Worse With RT/Cetuximab

0
Inferior overall and progression-free survival for radiation/cetuximab versus radiation/cisplatin
For patients with renal cell carcinoma

ASTRO: Stereotactic Ablative RT OK for RCC in Solitary Kidneys

0
Local control, cancer-specific survival at two years similar for patients with solitary, bilateral kidneys